- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Discrimination testing.
Displaying page 1 of 1.
EudraCT Number: 2009-013706-13 | Sponsor Protocol Number: TOP_LID_DPNP | Start Date*: Information not available in EudraCT |
Sponsor Name:Wilhelminenspital der Stadt Wien | ||
Full Title: ANALGESIC RESPONSE TO TRANSDERMAL LIDOCAINE IN PATIENTS WITH PAINFUL PERIPHERAL DIABETIC NEUROPATHY UNDERLYING DIFFERENT SENSORY PATTERNS | ||
Medical condition: In this study the effect of transdermal lidocaine in patients with painful peripheral diabetic neuropathy will be examined. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001958-10 | Sponsor Protocol Number: MD2018 | Start Date*: 2018-10-25 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Dexamethasone 21-dihydrogenphosphat and Triamcinolone acetonide in the treatment of Menière´s disease: a randomized, multicentric efficacy trial | ||
Medical condition: In our study we try to evaluate the effect of intratympanic Triamcinolon acetonide and Dexamethason 21-dihydrohenphosphat on vertigo control calculation, Hydrops MRI, vHIT (video head impuls test),... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2011-002609-31 | Sponsor Protocol Number: ISO-44-013 | Start Date*: 2012-01-27 | |||||||||||
Sponsor Name:Guerbet | |||||||||||||
Full Title: Diagnostic contribution of XENETIX® CT PERFUSION in pre-therapeutical assessment of hepatocellular carcinoma. | |||||||||||||
Medical condition: Subjects diagnosed for HCC and planned for surgery (tumorectomy, sectionectomy, segmentectomy, lobectomy or transplantation). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000942-21 | Sponsor Protocol Number: AIMS-2-CT1 | Start Date*: 2019-07-24 | |||||||||||||||||||||
Sponsor Name:Celso Arango | |||||||||||||||||||||||
Full Title: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents w... | |||||||||||||||||||||||
Medical condition: Autism Spectrum Disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004215-30 | Sponsor Protocol Number: BRD/05/155 | Start Date*: 2006-02-24 |
Sponsor Name:Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH) | ||
Full Title: Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernicke’s aphasia: a double-blinded, cross-over, randomised controlled trial. | ||
Medical condition: Wernicke's aphasia caused by a stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003498-41 | Sponsor Protocol Number: D-Fampr | Start Date*: 2015-09-22 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Effects of dalfampridine on mobility in the context of daily life | ||
Medical condition: Motor behaviour and cognition in multiple sclerosis patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000812-47 | Sponsor Protocol Number: SENS401-201 | Start Date*: 2018-09-24 | |||||||||||
Sponsor Name:SENSORION SA | |||||||||||||
Full Title: A two- part, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of SENS-401 in subjects with severe or profound sudden sensorineural hearing loss | |||||||||||||
Medical condition: Sudden sensorineural hearing loss (SSNHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) BG (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
